FEBRUARY

Industry Updates

Dermatology Times

FDA Approves Upadacitinib for Moderate to Severe AD

PR Newswire

Dermatology Devices Market Size Worth $34.3 Billion By 2030: Grand View Research, Inc.

Practical Dermatology

FDA Approves Pfizer's Cibinqo for Moderate-to-Severe AD in Adults

Healio

Vunakizumab shows early efficacy in plaque psoriasis

Medscape

Sorting Out Sleep Complaints in Children With AD Can Be Complex

MDLinx

Autoimmune drug shows promise in treating severe burns

New Dates Announced for SBS and MOPD 2022

LiVDerm is excited to announce NEW DATES for the 2022 South Beach Symposium (SBS) and Masters of Pediatric Dermatology (MOPD) conferences! We can't wait to see you August 11-14, 2022, at the coveted vacation destination, Loews Miami Beach Hotel in the heart of South Beach, Florida. REGISTER TODAY and mark your calendars for MOPD 2022 (August 11-12) and SBS 2022 (August 11-14).**

**If you previously registered for the February events, your conference enrollment will automatically transfer to the August dates, but you will need to rebook your hotel accommodations.

Best Blog

Read about the promising use of JAK inhibitors for some chronic and hard-to-treat skin conditions:

February is Black History Month

To recognize the 2022 Black History Month theme of Black Health and Wellness, we invite you to browse some of LiVDerm's popular resources for improving dermatologic care and outcomes for SOC patients:

• Peer-to-Peer Educational Toolkit: Racial Disparities in Dermatology
• Podcast: Treatment of Atopic Dermatitis and Psoriasis in Patients with Skin of Color
• Virtual Symposium: Tackling the Disparities in the Management of Atopic Dermatitis in African Americans: The Time is Now